Association Between Programmed Death-Ligand 1 Expression and the Vascular Endothelial Growth Factor Pathway in Angiosarcoma
Angiosarcoma is a vascular malignancy associated with a poor prognosis and chemotherapy resistance. The tumor immune microenvironment of angiosarcoma has not been characterized. We investigated the expression of programmed death-ligand 1 (PD-L1) and programmed death 1 (PD-1) in angiosarcoma and corr...
Main Authors: | Sanjay P. Bagaria, Zoran Gatalica, Todd Maney, Daniel Serie, Mansi Parasramka, Steven Attia, Murli Krishna, Richard W. Joseph |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2018.00071/full |
Similar Items
-
Breast Angiosarcoma: Case Series and Expression of Vascular Endothelial Growth Factor
by: Rondeep Brar, et al.
Published: (2009-12-01) -
Angiosarcoma in the mandible: Report of a rare case
by: Shirin Vashishth, et al.
Published: (2008-01-01) -
Cutaneous angiosarcoma of head and neck
by: Rita Vora, et al.
Published: (2014-01-01) -
Invasive Character of Malignant Endothelial Cells in Vinyl-Chloride-Induced Liver Angiosarcoma
by: INAGAKI, TAKAO, et al.
Published: (1990) -
Primary cardiac angiosarcoma: modern methods of diagnosis and treatment
by: Д. A. Sarachan, et al.
Published: (2020-05-01)